-
Delivra Health Brands Announces Appointment of New Director
-
Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)
-
Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025
-
Delivra Health Brands to Hold Conference Call to Discuss Results for the Year Ending June 30, 2025
-
Delivra's Dream Water(R) Brand Expands Global Footprint with Launch of 6-Count Sleep Gummies into the Gulf Cooperation Council (GCC) Market
-
Delivra Health Brands, and Its Dream Water(R) Brand, Partners with QVC to Bring Dream Water to Online Shoppers Across the US
-
Delivra Health Brands Engages Global One Media and Bergskogar for Investor Relations Services
-
Delivra Health and Its Brands Dream Water (TM) and Livrelief (TM) Report Positive Adjusted EBITDA(1) for Third Quarter of Fiscal 2025
-
Launch of 60-Count Sleep Gummies into the Middle Eastern Markets Drives Further Growth of Delivra Health Brands' Dream Water(R) Brand
-
Delivra Health Brands' Dream Water(R) Brand Drives Growth with Launch of 6-Count Sleep Gummies into the Canadian Market
-
Delivra Health and its Brands LivRelief(TM) and Dream Water(TM) Report Results for Second Quarter of Fiscal 2025
-
Delivra Health Brands to Hold Conference Call to Discuss Results for the Second Quarter of Fiscal 2025
-
Delivra Health Brands Announces Effective Date of Share Consolidation
-
Delivra Health Brands Announces Proposed Share Consolidation
-
Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025
-
Delivra Health Brands Reports Continued Growth with Positive Adjusted EBITDA(1) and Improved Financial Results for FY2024
-
Delivra Health Brands to Hold Conference Call to Discuss Results for the Year Ending June 30, 2024

